Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

A novel SIRT1 activator from Sirtris shows neuroprotective effects in optic neuritis in vivo

May 7, 2007

Tbeta4 cleared for phase II study in diabetics undergoing vitrectomy surgery

May 4, 2007

FDA approves AzaSite for bacterial conjunctivitis

May 2, 2007

Novagali cleared to begin U.S. phase III study of Nova-22007

April 30, 2007

CHMP to recommend that occult indication be deleted from Visudyne E.U. label

April 27, 2007

Enrollment ongoing in phase III study of Medidur for DME

April 27, 2007

Two phase II/III trials evaluate NT-501 in retinitis pigmentosa

April 20, 2007

FDA grants orphan drug status to ganciclovir for acute herpetic keratitis

April 19, 2007

Sirion raises financing to advance pipeline

April 13, 2007

Recent Asahi Kasei patent reports novel agents for treating glaucoma

April 12, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...